Millipore Sigma Vibrant Logo

233279 Coagulation Factor IX, Human Plasma

Coagulation Factor IX, Human Plasma, CAS 9001-28-9, is a native coagulation factor IX from human plasma. Sold on the basis of plasma equivalent units. 100 plasma equivalent units = 500 µg.

Coagulation Factor IX, Human Plasma: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: Antihemophilic Factor B, Christmas Factor, Plasma Thromboplastin Component, PTC

View This Product on Sigma-Aldrich
233279
価格＆在庫状況を照会

概要

Replacement Information

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
233279-100UCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 100 u
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewNative coagulation factor IX from human plasma. Sold on the basis of plasma equivalent units. 100 plasma equivalent units are equal to 500 µg of Factor IX. In vivo, activation of Factor IX to IXa occurs via either the tissue factor/Factor VIIa complex (the extrinsic pathway), or Factor XIa (the intrinsic pathway). Activated Factor IXa, in a complex with Factor VIIIa, can then convert Factor X to Xa, the catalytic component of the prothrombinase complex.
      Catalogue Number233279
      Brand Family Calbiochem®
      SynonymsAntihemophilic Factor B, Christmas Factor, Plasma Thromboplastin Component, PTC
      References
      Product Information
      CAS number9001-28-9
      FormLiquid
      FormulationIn 100 mM NaCl, 20 mM Tris-HCl, 1 mM benzamidine, pH 7.5.
      HS Code3002 12 19
      Quality LevelMQ200
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Specific Activity≥150 units/mg protein (clotting assay). Clotting activity is determined by comparison to a standard curve produced using normal pooled human plasma
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSEC6045000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      233279-100UCN 04055977217803

      Documentation

      Coagulation Factor IX, Human Plasma (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Coagulation Factor IX, Human Plasma 試験成績書（CoA）

      タイトルロット番号
      233279
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-January-2008 JSW
      SynonymsAntihemophilic Factor B, Christmas Factor, Plasma Thromboplastin Component, PTC
      DescriptionNative coagulation factor IX from human plasma. Sold on the basis of plasma equivalent units. 100 plasma equivalent units are equal to 500 µg of Factor IX. In vivo, activation of Factor IX to IXa occurs via either the tissue factor/Factor VIIa complex (the extrinsic pathway), or Factor XIa (the intrinsic pathway). Activated Factor IXa, in a complex with Factor VIIa, can then convert Factor X to Xa, the catalytic component of the prothrombinase complex.
      FormLiquid
      FormulationIn 100 mM NaCl, 20 mM Tris-HCl, 1 mM benzamidine, pH 7.5.
      Concentration Label Please refer to vial label for lot-specific concentration
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      CAS number9001-28-9
      RTECSEC6045000
      Purity≥95% by SDS-PAGE
      Specific activity≥150 units/mg protein (clotting assay). Clotting activity is determined by comparison to a standard curve produced using normal pooled human plasma
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      Merck USA index14, 3922